First Quarter 2025 Earnings Call May 7, 2025 FORWARD-LOOKING STATEMENTS This presentation includes forward-looking statements that reflect our current views with respect to, among other things, our 2025 outlook, our operations and our financial performance. These forward-looking statements are included throughout this presentation and relate to matters such as our industry, business strategy, goals and expectations concerning our market position, future operations, strategic priorities and initiatives, fore ...

Q1 2025 Earnings Results Review May 7, 2025 Forward-Looking Statements • Today's presentation includes forward-looking statements that reflect Bunge's current views with respect to future events, financial performance and industry conditions. • These forward-looking statements are subject to various risks and uncertainties. Bunge has provided additional information in its reports on file with the Securities and Exchange Commission concerning factors that could cause actual results to differ materially from ...

2025 Q2 Earnings May 7, 2025 EMERSON | 1 Safe Harbor Statement Statements in this presentation and our commentary and responses to questions that are not strictly historical may be "forward-looking" statements, which involve risks and uncertainties, and Emerson undertakes no obligation to update any such statements to reflect later developments. These risks and uncertainties include the scope, duration and ultimate impacts of the Russia-Ukraine and other global conflicts, as well as economic and currency co ...

Reimagining Mental Health Q1 2025 Earnings Presentation • May 7, 2025 Forward-Looking Statements DISCLAIMERS Cautionary Note Regarding Forward-Looking Statements This presentation and related oral statements, including during any question and answer portion of the presentation, contain forward-looking statements about LifeStance Health Group, Inc. and its subsidiaries ("LifeStance") and the industry in which LifeStance operates, including statements regarding: full-year and second quarter guidance and manag ...

Investor Presentation First Quarter 2025 May 2025 Forward-Looking Statements - Disclaimer Certain statements in this presentation are forward-looking statements, including our Q2 2025 and full-year 2025 guidance and our expectations for Realize, our new performance advertising platform. Forward-looking statements generally relate to future events including future financial or operating performance of Taboola.com Ltd. (the "Company"). In some cases, you can identify forward-looking statements by terminology ...

Financial Performance & Outlook - Teva reported a 5% revenue increase in Q1 2025 compared to Q1 2024 [18] - Non-GAAP EPS increased by 8% in Q1 2025 compared to Q1 2024 [18] - Free cash flow saw a significant increase of 238% in Q1 2025 compared to Q1 2024 [18] - The company is on track to achieve a 30% operating profit margin (OPM) by 2027 [44, 93] - Teva is targeting ~$700 million in net savings by 2027 through modernization efforts [39, 95] Key Products & Growth Drivers - AUSTEDO U S revenue grew by 40% year-over-year in Q1 2025, reaching $396 million [24] - Global AUSTEDO revenue reached $411 million in Q1 2025, a 39% year-over-year increase [21, 24] - UZEDY revenues increased by 156% year-over-year in Q1 2025, reaching $39 million [21, 30] - AJOVY global revenues grew by 26% year-over-year in Q1 2025, reaching $139 million [21, 32, 33] Generics & Biosimilars - Global generics experienced a 3% growth in Q1 2025 [21, 34]

Trimble Inc. First Quarter 2025 Earnings Summary © 2025 Trimble, Inc - All Rights Reserved Forward-Looking Statements Certain statements made in this presentation and any subsequent Q&A period are forward-looking statements, within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and are made pursuant to the safe harbor provisions of the Securities Litigation Reform Act of 1995. These statements include expectations about our future financial and operational results and expecta ...

Q1-2025 Earnings Presentation James Ray – President & Chief Executive Officer Andy Cheung – Executive Vice President & Chief Financial Officer May 7, 2025 Forward Looking Statements and Non-GAAP Financial Measures These slides contain forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended. For this purpose, any statements contained herein that are not statements of historical fact, including w ...

Financial Performance - Total revenue for Q1 2025 was $107.9 million, a 2.2% increase year-over-year[12, 21] - Total payment volume reached $20.6 billion in Q1 2025, up 3.7% from $19.9 billion in Q1 2024[16, 33] - Non-GAAP gross profit was $79.1 million in Q1 2025, resulting in a Non-GAAP gross margin of 73.3%, a 90 basis points expansion year-over-year[37] - Adjusted EBITDA margin for Q1 2025 was 16.2%[40] Operational Metrics - Total transactions processed in Q1 2025 were 19.7 million, a 1.9% increase from 19.3 million in Q1 2024[13, 23] - Total transaction yield was $5.48 in Q1 2025, a 0.2% increase from $5.47 in Q1 2024[28] Financial Position - The company's cash and cash equivalents stood at $389.3 million as of Q1 2025[43] - Long-term debt remained at $63.2 million in Q1 2025[43] Non-GAAP Measures - The presentation includes several non-GAAP financial measures such as Non-GAAP Gross Profit, Adjusted EBITDA, and Non-GAAP Net Income (Loss), which are used to supplement GAAP measures and provide insights into the company's operating performance[6, 8, 9]

First Quarter 2025 Results May 7, 2025 1 Safe Harbor Statements Cautionary Note Regarding Forward-Looking Statements The information presented herein includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements, which are based on current expectations, estimates and projections about the industry and markets in which Vistra Corp. ("Vistra") operates and beliefs of and assumptions made by Vistra's management, involve risks an ...